Table 4.
Clinical characteristics of the BCR- and BCR+ datasets.
| BCR- | BCR+ | P value | |
|---|---|---|---|
| (N=100) | (N=31) | ||
| Age (year) | |||
| Mean (SD) | 72.3 (7.55) | 70.6 (8.00) | 0.335 |
| tPSA (ng/dL) | |||
| Median [Q1, Q3] | 36.8 [13.9,95.9] | 75.2 [17.8,472] | 0.044 |
| PI-RADS score | |||
| 4 | 12 (12.0%) | 2 (6.5%) | 0.589 |
| 5 | 88 (88.0%) | 29 (93.5%) | |
| PCa location | |||
| PZ and TZ | 8 (8.0%) | 2 (6.5%) | 0.352 |
| PZ only | 6 (6.0%) | 0 (0%) | |
| TZ only | 86 (86.0%) | 29 (93.5%) | |
| PCa volume (mm3) | |||
| Median [Q1, Q3] | 6190 [2240,19500] | 23800 [5760,41300] | 0.004 |
| PCa ADC value (*10^-3 s/mm3) | |||
| Mean (SD) | 802 (133) | 756 (103) | 0.111 |
| ISUP | |||
| 1 | 2 (2.0%) | 2 (6.5%) | 0.077 |
| 2 | 12 (12.0%) | 0 (0%) | |
| 3 | 17 (17.0%) | 3 (9.7%) | |
| 4 | 22 (22.0%) | 5 (16.1%) | |
| 5 | 47 (47.0%) | 21 (67.7%) | |
| Stage | |||
| TxN0M0 | 55 (55.0%) | 7 (22.6%) | <0.001 |
| TxN1M0 | 18 (18.0%) | 2 (6.5%) | |
| TxNxM1 | 27 (27.0%) | 22 (71.0%) | |
| Treatment | |||
| Radiotherapy | 4 (4.0%) | 0 (0%) | <0.001 |
| Hormonal therapy | 22 (22.0%) | 30 (96.8%) | |
| Comprehensive therapy | 74 (74.0%) | 1 (3.2%) | |